Mustafa Comoglu

Dr. Mustafa Comoglu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2024 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
MCMustafa Comoglu
Mustafa Comoglu
FAFatih Acehan
Fatih Acehan
OIOsman Inan
Osman Inan
BDBurak Furkan Demir
Burak Furkan Demir
YYYusufcan Yılmaz
Yusufcan Yılmaz
ESEnes Seyda Sahiner
Enes Seyda Sahiner

23 November 2021 in Blood Purification
Verified
Journal Article
Closed access
PDF file
MCMustafa Comoglu
Mustafa Comoglu
FDFatih Dede
Fatih Dede
EYEzgi Coskun Yenigun
Ezgi Coskun Yenigun
CTCanan Topcuoglu
Canan Topcuoglu
OIOsman Inan
Osman Inan
IAIhsan Ates
Ihsan Ates
Introduction: There is insufficient data on the role of the medium cutoff (MCO) membranes in the clearance of pro-inflammatory cytokines and oxidant radicals in patients with sepsis requiring hemodialysis. Methods: The study consisted of 38 septic patients who developed acute kidney injury (AKI) and who were scheduled to undergo 2 sessions of hemodialysis. Nineteen patients underwent their first dialysis session with the MCO membrane and 19 patients with the high-flux (HF) membrane. In the second session, the membranes were switched. Pro-inflammatory cytokine and oxidative marker levels were measured in blood samples obtained before and after both dialysis sessions. Reduction ratios were compared for the 2 types of hemodialysis membranes. Results: After the first session, there was a greater reduction in tumor necrosis factor (TNF)-α with the MCO membrane (28.2 ± 21.1 vs. 8.0 ± 6.6, p = 0.001). After the second session, there was a greater reduction in interleukin (IL)-6 (27.8 ± 26.5 vs. 5.9 ± 13.3, p = 0.003) and IL-1β (20.5 ± 21.1 vs. 4.0 ± 6.5, p = 0.004) with the MCO membrane. When the first and second sessions of all 38 patients were compared, the reductions in TNF-α, IL-6, and IL-1β were consistently greater for MCO than HF (p = 0.001, p = 0.006, p < 0.001, respectively). The reductions in total antioxidant status, total oxidant status, and myeloperoxidase were not statistically different for the 2 types of dialysis membranes. Conclusions: MCO membrane was superior to HF membrane in the removal of cytokines in septic patients with AKI. However, a similar effect was not observed for oxidative stress markers.

5 June 2025 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Open access
MCMustafa Comoglu
Mustafa Comoglu
FAFatih Acehan
Fatih Acehan
ESEnes Seyda Sahiner
Enes Seyda Sahiner
HCHuseyin Camli
Huseyin Camli
ZKZeki Mesut Yalin Kilic
Zeki Mesut Yalin Kilic
IAIhsan Ates
Ihsan Ates
Background/Purpose: Current guidelines do not provide specific recommendations regarding the timing of endoscopic retrograde cholangiopancreatography (ERCP) in patients with acute cholangitis (AC) concurrent with acute gallstone pancreatitis (AGP). This study evaluated the impact of ERCP timing on clinical outcomes.Methods: A total of 144 patients diagnosed with AC concurrent with AGP between March 2019 and February 2024 were included in the study. Patients were classified into two groups: urgent ERCP group (ERCP ≤ 24 h) and non‐urgent ERCP group (ERCP 24–72 h). Clinical outcomes were compared using propensity score matching (PSM) analysis.Results: After PSM, two well‐balanced groups of 55 patients were created. The median ERCP time was 18 (13–21) hours in the urgent group and 41 (36–54) hours in the non‐urgent group. There was no significant difference in composite outcomes, including in‐hospital mortality, prolonged hospital stay, severe pancreatitis, or late localized/systemic complications of pancreatitis [11 (20%) vs. 16 (29.1%); p = 0.268]. Additionally, no significant difference was observed between the groups regarding prolonged hospital stay (p = 0.506), ICU admission (p = 0.680), or in‐hospital mortality (p = 0.161).Conclusions: Urgent ERCP within 24 h does not significantly improve clinical outcomes compared to ERCP performed within 24–72 h in patients with AC and AGP.

26 October 2024 in Medicina
Verified
Journal Article
Open access
PDF file
MCMustafa Comoglu
Mustafa Comoglu
FAFatih Acehan
Fatih Acehan
ESEnes Seyda Sahiner
Enes Seyda Sahiner
CKCagdas Kalkan
Cagdas Kalkan
ECEzgi Comoglu
Ezgi Comoglu
IAIhsan Ates
Ihsan Ates
Background: The data on acute cholangitis in the octogenarian population are very limited. This study aimed to examine the clinical characteristics of acute cholangitis and complications related to endoscopic retrograde cholangiopancreatography (ERCP) in octogenarians. Materials and Methods: This study was conducted prospectively between July 2022 and December 2023 and included 250 patients aged 65 years and older. Patients eligible for the study were divided into two groups: those aged ≥80 years (octogenarian) and those aged 65–79 years (non-octogenarian). These two groups were compared in terms of the clinical characteristics of cholangitis and ERCP-related complications. In addition, factors associated with in-hospital mortality were evaluated. Results: Out of 250 patients, 87 (34.8%) were octogenarians and 163 (65.2%) were non-octogenarians. The median age was 76 (69–82) years. Although the octogenarian group had higher rates of severe illness and intensive care unit admissions (p < 0.001 and p = 0.002, respectively), there were no significant differences in in-hospital mortality (p = 0.359) or ERCP-related complications (p = 0.417). Malignant etiology (odds ratio [OR]: 5.68, 95% confidence interval [CI]: 2.11–15.3), hypoalbuminemia (OR 0.18, 95% CI 0.07–0.45), and qSOFA score ≥ 2 (OR: 6.5, 95% CI: 1.7–24.5) were independent risk factors for in-hospital mortality. Conclusions: Being over 80 years old is not an indicator of poor outcomes, and ERCP can be safely performed on these patients. However, elderly patients with hypoalbuminemia, malignant etiology, or a qSOFA score of ≥2 should be closely monitored, regardless of their age.

8 January 2026 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
FAFatih Acehan
Fatih Acehan
CKCagdas Kalkan
Cagdas Kalkan
YYYusufcan Yilmaz
Yusufcan Yilmaz
MCMustafa Comoglu
Mustafa Comoglu
FKFatih Mehmet Kayserili
Fatih Mehmet Kayserili
IAIhsan Ates
Ihsan Ates

10 December 2024 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
PDF file
MCMustafa Comoglu
Mustafa Comoglu
GOGüzelali Ozdemir
Güzelali Ozdemir
BSBaran Sarıkaya
Baran Sarıkaya
FAFatih Acehan
Fatih Acehan
OBOlgun Bingol
Olgun Bingol
EŞEnes Seyda Şahiner
Enes Seyda Şahiner
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.